Viewing Study NCT03000660


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-04-22 @ 4:24 PM
Study NCT ID: NCT03000660
Status: TERMINATED
Last Update Posted: 2020-08-21
First Post: 2016-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Sponsor: Tufts Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module